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Background/Introduction
Oral anticoagulation with a vitamin K antagonist (usually
warfarin) is recommended for lifelong management post
mechanical valve insertion. Effects of warfarin are highly
variable and dosing outcomes are usually seen after three
or four days. This audit was conducted in line with recom-
mendations from patient safety alert 18 to review current
practice of warfarin prescribing.
Aims/Objectives
To assess warfarin initiation in patients post mechanical
valve insertion at the Heart Hospital.
Objectives
• 100% of patients to have a baseline international
normalised ratio (INR)
• 100% of patients to have INRs on days 3, 4 and 7 (if
appropriate)
• 100% of patients to have dose adjusted on day 4
according to Trust guidelines
• 100% of patients to have consistent dosing on days 1, 2
and 3
• 100% of patients on warfarin prior to admission
would have warfarin restarted at the same dose
• 0% of patients to have an INR > 3.5
Method
This audit was conducted at The Heart Hospital and data
collected retrospectively between November 2013 and
August 2014. Patient notes, drug charts, electronic CDR
and ICIP systems were used to collect inpatient doses,
INRs and indications for warfarin. Pre-operative use of
warfarin, and dosing, was also determined.
Results
There were 97 patients identified who had cardiac surgery
which included at least one mechanical valve, of which a
significant proportion were on warfarin prior to admission
(22%, n = 21).
Results
1. Baseline INR - 100% (97/97)
2. INR Day 2 - 82% (80/97)
3. INR Day 3 - 91% (87/96)
4. INR Day 4 - 87% (79/91)
5. INR Day 7 - 87% (34/39)
6. Consistency of first 3 doses - 30% (29/97)
7. INR > 3.5 - 12% (12/97), > 4 - 6% (6/97)
Discussion/Conclusion
The effect of warfarin is highly variable and exhibits much
inter-patient variability which requires an individually
tailored dosing regime when initiating warfarin. This audit
suggests that warfarin prescribing is unpredictable follow-
ing mechanical valve insertion and has led to clinically
significant INR excursions of >4.0 in 6% of patients, which
in turn suggests that improvements in prescribing could
be made.
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